Stanford University
Showing 5,201-5,220 of 36,304 Results
-
Xiaoke Chen
Associate Professor of Biology
Current Research and Scholarly InterestsOur goal is to understand how brain circuits mediate motivated behaviors and how maladaptive changes in these circuits cause mood disorders. To achieve this goal, we focus on studying the neural circuits for pain and addiction, as both trigger highly motivated behaviors, whereas, transitioning from acute to chronic pain or from recreational to compulsive drug use involves maladaptive changes of the underlying neuronal circuitry.
-
Yi-Ren Chen, MD, MPH, FAANS
Adjunct Clinical Assistant Professor, Neurosurgery
BioDr. Chen is a neurosurgeon and spine surgeon and Chief of Neurosurgery with Mercy Medical Group, Sacramento County, CA, as well as an Adjunct Clinical Assistant Professor of Neurosurgery at Stanford University. After double majoring in biology and history at Stanford, he obtained his MD from Stanford and MPH from Johns Hopkins. He subsequently completed neurosurgery residency and complex spine fellowship at Stanford. Dr. Chen has over 150 peer-reviewed papers, book chapters, talks, and abstracts. He serves the greater Sacramento area and beyond.
Clinical interests:
Minimally invasive spine, scoliosis and deformity, redo/ revision spinal surgery, complex spine, general neurosurgery
Administrative Appointments:
Chief of Neurosurgery, Mercy Medical Group/ Dignity Health Sacramento, Sacramento County, CA
Director (North)/ Board of Directors, California Association of Neurological Surgeons (CANS)
Professional Education:
Undergraduate: Stanford University (BA/ BS)
Medical School: Stanford University (MD)
Masters: Johns Hopkins (MPH)
Residency: Stanford University (Neurosurgery)
Fellowship: Stanford University (Minimally Invasive and Complex Deformity Spine)
Fellowship: San Diego Spine Foundation (Visiting Fellow in Minimally Invasive Spine)
Board Certification: American Board of Neurological Surgery, Neurosurgery
Research interests:
Clinical outcomes research on spine patients utilizing both large-scale nationwide databases and single-center patient information, focusing on improving quality of care, patient satisfaction, and hospital-wide outcomes. -
Ying-Li Chen
Assistant Director, Business Development and Strategic Marketing, Office of Technology Licensing (OTL)
BioYing-Li Chen is an Assistant Director, Business Development and Strategic Marketing and manages a team ranging from associates to interns at the Stanford Office of Technology Licensing (OTL). She joined OTL in 2019 and established the Business Development and Marketing Team to lead the technology marketing and public relations efforts. She connects industry partners with inventors to commercialize Stanford’s research and innovation through licensing, strategic alliances, and industry sponsored research. She has more than 11 years of experience in technology commercialization and entrepreneurship at Stanford University, University of California, San Francisco, and Johns Hopkins University.
-
Yiyun Chen
Postdoctoral Scholar, Stanford Cancer Institute
BioYiyun Chen, Ph.D. is a Postdoctoral Fellow at Professor Crystal Mackall’s group at Stanford Cancer Institute.
Dr. Chen studied biochemistry and structural biology in her undergraduate and master trainings at The Hong Kong University of Science and Technology, where she eventually obtained her Ph.D. degree in computational biology under the supervision of Professor Jiguang Wang. During her Ph.D. training, she has developed her skill sets in analyzing and integrating various types of patient-derived sequencing data, published three first-author and four co-author papers, and received two awards for top postgraduate students. Through interdisciplinary collaborations with cancer biologist and clinicians in US and Asia, her work has uncovered tumor-specific immune cell subtypes and novel noncoding RNAs and generated new insights into precision medicine in glioma, lymphoma and gastric cancer.
Applying her expertise in computational cancer biology and immunology, her current research is focused on identifying molecular mechanisms that contribute to the clinical outcomes of patients undergoing CAR-T immunotherapy. At Mackall Lab, she will contribute to tailoring computational pipelines for profiling the spatiotemporal dynamics of the tumor and immune microenvironment and translate new discoveries into cancer therapeutics.